Health GLP-1RAs Reduce Cardiovascular & Kidney Risks in Type 1 Diabetes: A Target Trial Emulation Study by Grace Chen March 22, 2026 written by Grace Chen March 22, 2026 69 Related 0 comments 0 FacebookTwitterPinterestEmail Grace Chen Board-certified physician and medical writer. Translates research into practical health advice and public-health coverage. previous post ICE at Airports: Trump Plan Sparks Shutdown Fight & Security Concerns next post Rams 2026 NFL Draft: Adding to a Super Bowl-Contending Roster You may also like Measles Case Confirmed at Dulles International Airport June 21, 2026 GLP-1 Drugs Linked to 35% Lower Breast Cancer... June 3, 2026 CDC: U.S. smoking rate hits record low at... May 30, 2026 4-Second Exercise ‘Snacks’ May Help Lower Blood Sugar... May 28, 2026 US Preventive Services Task Force Says Multivitamins Lack... May 28, 2026 Biological Age Gap Predicts Higher Mortality Risk by... May 27, 2026 American missionary survives Bundibugyo Ebola after Congo evacuation May 26, 2026 Italy confirms Ebola cases negative after Uganda exposure May 26, 2026 Antibiotics Devastate Gut Microbiome May 25, 2026 Pennsylvania Schools Spread Misinformation on Vaccines May 25, 2026 Leave a Comment Cancel Reply Notify me of follow-up comments by email. Notify me of new posts by email. Δ
